Skip to main content
Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
68.84
+1.78 (2.65%)
At close: Dec 20, 2024, 4:00 PM
68.82
-0.02 (-0.03%)
After-hours: Dec 20, 2024, 4:36 PM EST

Incyte Revenue

Incyte had revenue of $1.14B in the quarter ending September 30, 2024, with 23.81% growth. This brings the company's revenue in the last twelve months to $4.08B, up 12.94% year-over-year. In the year 2023, Incyte had annual revenue of $3.70B with 8.87% growth.

Revenue (ttm)
$4.08B
Revenue Growth
+12.94%
P/S Ratio
3.63
Revenue / Employee
$1,614,842
Employees
2,524
Market Cap
13.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 20192.16B276.88M14.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG 21.46B
Tenet Healthcare 20.97B
DaVita 12.67B
Dr. Reddy's Laboratories 3.58B
Genmab 2.97B
BioMarin Pharmaceutical 2.75B
Revvity 2.72B
Neurocrine Biosciences 2.24B
Revenue Rankings

INCY News

More News